PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$31.85
+1.01 (+3.28%)
Analyst Consensus
Strong Sell
10
Analysts
Moderate
Coverage
Buy 1 10%
Hold 5 50%
Sell 4 40%
Price Target
Analyst Price Target +238.2% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $31.85
Current
$31.85
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
125.9%
Low target
Base Case
$107.71
+238.2%
Avg target
Bull Case
$157.72
+395.2%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$60.08
-47.0% from high
52-Week Low
$23.57
+35.1% from low
50-Day SMA
$42.00
-24.2% vs SMA
200-Day SMA
$35.40
-10.0% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$107.71
+79.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%